Interstitial Lung Disease PBMC
About: Interstitial lung disease PBMC PBMCs collected from interstitial lung disease (ILD) patients, supporting fibrosis and autoimmune lung research.
Interstitial lung disease PBMC
PBMC samples from donors diagnosed with Interstitial lung disease are collected and processed under rigorous standards. These samples support research into alveolar damage and fibrotic remodeling, offering insights into disease mechanisms, biomarker discovery, and therapeutic development.
Product Features
- PBMC isolated from clinically confirmed Interstitial lung disease donors
- Rigorous donor screening and sample quality checks
- Suitable for downstream applications such as flow cytometry, RNA-seq, ELISA, and qPCR
De-identified Donor Data
- Age, sex, race, medication, diagnosis method, disease severity/stage
- Optional: comorbidities, lab values, and clinical history
Applications
- Immunophenotyping
- Transcriptomics & proteomics
- Biomarker validation
- Therapeutic development and screening
Quality and Compliance
- IRB-approved protocols
- Informed donor consent
- Standardized collection and processing SOPs
Ordering & Shipping
Samples are available in both standard and custom volumes to meet your research needs.
International Orders: For international shipments or country-specific documentation requirements, please contact us at learnmore@sanguinebio.com to ensure compliance with your local regulations.
Protocols & Documentation
-
Download
PBMC Isolation from Whole Blood
Standard operating procedure for isolating peripheral blood mononuclear cells from whole blood using density-gradient separation.
-
Download
Immune Cell Isolation
Guidelines for isolating immune cell populations with validated enrichment steps, purity checkpoints, and documentation.
-
Download
Choosing the Right PBMC Configuration
Reference guide comparing PBMC formats, cryopreservation states, and study-fit recommendations for your application.
-
Download
Thawing Cryopreserved PBMC
Validated thawing protocol to recover viable cryopreserved PBMCs while minimizing activation and loss of function.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
PBMC
Frequently Asked Questions
1 Answer
YES – All collections are conducted under IRB-approved protocols and electronic informed consent. Sanguine utilizes Advarra and WCG IRB for oversight.
1 Answer
YES – with the exception of GMP leukopaks, all our products are research use only (RUO).
1 Answer
Our complete catalog can be found here: https://sanguinebio.com/products/
1 Answer
Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.
1 Answer
Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.
1 Answer
Sanguine offers flexible prospective colleciton services to tailored to fit your research. For more information and request a quote, please see: https://sanguinebio.com/prospective-biospecimen-collection-services/
1 Answer
Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.
1 Answer
YES – we have in-stock inventory which can be found here https://sanguinebio.com/products/?pro_inventory=inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.
1 Answer
Each sample from a different individual – Unique donor means each sample comes from a different person, ensuring biological diversity in your study.
1 Answer
YES – Unique donors can be specified and guaranteed based on your requirements.
1 Answer
For information about sample quality, please see: https://sanguinebio.com/quality-and-compliance/
1 Answer
YES – “IRB-approved collection protocols” and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.
Ask a Question
Need a custom PBMC cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.